
The global market for Prefillable COP Polymer Syringes was valued at US$ 151 million in the year 2024 and is projected to reach a revised size of US$ 195 million by 2031, growing at a CAGR of 3.6% during the forecast period.
Prefillable COP polymer syringes are high-performance syringes made from cyclic olefin polymer (COP) and specifically designed for prefilled medications. Compared to traditional glass syringes, COP syringes offer excellent transparency, chemical resistance, and high breakage resistance while eliminating the risk of glass particle contamination. Their lightweight design and superior sealing capabilities make them ideal for packaging sensitive pharmaceuticals such as biologics, vaccines, oncology drugs, and other high-sensitivity medications. Additionally, COP syringes reduce drug adsorption, ensuring drug stability, and are suitable for both lyophilized and liquid formulations. Due to their outstanding performance, COP prefillable polymer syringes are widely used in advanced medical and biopharmaceutical applications.
North American market for Prefillable COP Polymer Syringes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Prefillable COP Polymer Syringes is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Prefillable COP Polymer Syringes include BD, Gerresheimer, Nipro Corporation, Schott, Baxter BioPharma Solution, Rovi CM, Terumo, Vetter, Catalent, Taisei Kako, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Prefillable COP Polymer Syringes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prefillable COP Polymer Syringes.
The Prefillable COP Polymer Syringes market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Prefillable COP Polymer Syringes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Prefillable COP Polymer Syringes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BD
Gerresheimer
Nipro Corporation
Schott
Baxter BioPharma Solution
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
Roselabs Group
Segment by Type
Needle Syringe
Luer Lock Syringe
Segment by Application
Vaccine
Antithrombotic Drugs
Bioengineered Drugs
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Prefillable COP Polymer Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Prefillable COP Polymer Syringes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report. 
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Prefillable COP Polymer Syringes Âé¶¹Ô´´ Overview
1.1 Product Definition
1.2 Prefillable COP Polymer Syringes by Type
1.2.1 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Value Comparison by Type (2024 VS 2031)
1.2.2 Needle Syringe
1.2.3 Luer Lock Syringe
1.3 Prefillable COP Polymer Syringes by Application
1.3.1 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Value by Application (2024 VS 2031)
1.3.2 Vaccine
1.3.3 Antithrombotic Drugs
1.3.4 Bioengineered Drugs
1.3.5 Other
1.4 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Size Estimates and Forecasts
1.4.1 Global Prefillable COP Polymer Syringes Revenue 2020-2031
1.4.2 Global Prefillable COP Polymer Syringes Sales 2020-2031
1.4.3 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Prefillable COP Polymer Syringes Âé¶¹Ô´´ Competition by Manufacturers
2.1 Global Prefillable COP Polymer Syringes Sales Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.2 Global Prefillable COP Polymer Syringes Revenue Âé¶¹Ô´´ Share by Manufacturers (2020-2025)
2.3 Global Prefillable COP Polymer Syringes Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Prefillable COP Polymer Syringes, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Prefillable COP Polymer Syringes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Prefillable COP Polymer Syringes, Product Type & Application
2.7 Global Key Manufacturers of Prefillable COP Polymer Syringes, Date of Enter into This Industry
2.8 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Competitive Situation and Trends
2.8.1 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Concentration Rate
2.8.2 The Global 5 and 10 Largest Prefillable COP Polymer Syringes Players Âé¶¹Ô´´ Share by Revenue
2.8.3 Global Prefillable COP Polymer Syringes Company Type and Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Scenario by Region
3.1 Global Prefillable COP Polymer Syringes Âé¶¹Ô´´ Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Prefillable COP Polymer Syringes Sales by Region: 2020-2031
3.2.1 Global Prefillable COP Polymer Syringes Sales by Region: 2020-2025
3.2.2 Global Prefillable COP Polymer Syringes Sales by Region: 2026-2031
3.3 Global Prefillable COP Polymer Syringes Revenue by Region: 2020-2031
3.3.1 Global Prefillable COP Polymer Syringes Revenue by Region: 2020-2025
3.3.2 Global Prefillable COP Polymer Syringes Revenue by Region: 2026-2031
3.4 North America Prefillable COP Polymer Syringes Âé¶¹Ô´´ Facts & Figures by Country
3.4.1 North America Prefillable COP Polymer Syringes Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Prefillable COP Polymer Syringes Sales by Country (2020-2031)
3.4.3 North America Prefillable COP Polymer Syringes Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Prefillable COP Polymer Syringes Âé¶¹Ô´´ Facts & Figures by Country
3.5.1 Europe Prefillable COP Polymer Syringes Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Prefillable COP Polymer Syringes Sales by Country (2020-2031)
3.5.3 Europe Prefillable COP Polymer Syringes Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Prefillable COP Polymer Syringes Âé¶¹Ô´´ Facts & Figures by Region
3.6.1 Asia Pacific Prefillable COP Polymer Syringes Âé¶¹Ô´´ Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Prefillable COP Polymer Syringes Sales by Region (2020-2031)
3.6.3 Asia Pacific Prefillable COP Polymer Syringes Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Prefillable COP Polymer Syringes Âé¶¹Ô´´ Facts & Figures by Country
3.7.1 Latin America Prefillable COP Polymer Syringes Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Prefillable COP Polymer Syringes Sales by Country (2020-2031)
3.7.3 Latin America Prefillable COP Polymer Syringes Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Prefillable COP Polymer Syringes Âé¶¹Ô´´ Facts & Figures by Country
3.8.1 Middle East and Africa Prefillable COP Polymer Syringes Âé¶¹Ô´´ Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Prefillable COP Polymer Syringes Sales by Country (2020-2031)
3.8.3 Middle East and Africa Prefillable COP Polymer Syringes Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Prefillable COP Polymer Syringes Sales by Type (2020-2031)
4.1.1 Global Prefillable COP Polymer Syringes Sales by Type (2020-2025)
4.1.2 Global Prefillable COP Polymer Syringes Sales by Type (2026-2031)
4.1.3 Global Prefillable COP Polymer Syringes Sales Âé¶¹Ô´´ Share by Type (2020-2031)
4.2 Global Prefillable COP Polymer Syringes Revenue by Type (2020-2031)
4.2.1 Global Prefillable COP Polymer Syringes Revenue by Type (2020-2025)
4.2.2 Global Prefillable COP Polymer Syringes Revenue by Type (2026-2031)
4.2.3 Global Prefillable COP Polymer Syringes Revenue Âé¶¹Ô´´ Share by Type (2020-2031)
4.3 Global Prefillable COP Polymer Syringes Price by Type (2020-2031)
5 Segment by Application
5.1 Global Prefillable COP Polymer Syringes Sales by Application (2020-2031)
5.1.1 Global Prefillable COP Polymer Syringes Sales by Application (2020-2025)
5.1.2 Global Prefillable COP Polymer Syringes Sales by Application (2026-2031)
5.1.3 Global Prefillable COP Polymer Syringes Sales Âé¶¹Ô´´ Share by Application (2020-2031)
5.2 Global Prefillable COP Polymer Syringes Revenue by Application (2020-2031)
5.2.1 Global Prefillable COP Polymer Syringes Revenue by Application (2020-2025)
5.2.2 Global Prefillable COP Polymer Syringes Revenue by Application (2026-2031)
5.2.3 Global Prefillable COP Polymer Syringes Revenue Âé¶¹Ô´´ Share by Application (2020-2031)
5.3 Global Prefillable COP Polymer Syringes Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Prefillable COP Polymer Syringes Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Gerresheimer
6.2.1 Gerresheimer Company Information
6.2.2 Gerresheimer Description and Business Overview
6.2.3 Gerresheimer Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Gerresheimer Prefillable COP Polymer Syringes Product Portfolio
6.2.5 Gerresheimer Recent Developments/Updates
6.3 Nipro Corporation
6.3.1 Nipro Corporation Company Information
6.3.2 Nipro Corporation Description and Business Overview
6.3.3 Nipro Corporation Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Nipro Corporation Prefillable COP Polymer Syringes Product Portfolio
6.3.5 Nipro Corporation Recent Developments/Updates
6.4 Schott
6.4.1 Schott Company Information
6.4.2 Schott Description and Business Overview
6.4.3 Schott Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Schott Prefillable COP Polymer Syringes Product Portfolio
6.4.5 Schott Recent Developments/Updates
6.5 Baxter BioPharma Solution
6.5.1 Baxter BioPharma Solution Company Information
6.5.2 Baxter BioPharma Solution Description and Business Overview
6.5.3 Baxter BioPharma Solution Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Baxter BioPharma Solution Prefillable COP Polymer Syringes Product Portfolio
6.5.5 Baxter BioPharma Solution Recent Developments/Updates
6.6 Rovi CM
6.6.1 Rovi CM Company Information
6.6.2 Rovi CM Description and Business Overview
6.6.3 Rovi CM Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Rovi CM Prefillable COP Polymer Syringes Product Portfolio
6.6.5 Rovi CM Recent Developments/Updates
6.7 Terumo
6.7.1 Terumo Company Information
6.7.2 Terumo Description and Business Overview
6.7.3 Terumo Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Terumo Prefillable COP Polymer Syringes Product Portfolio
6.7.5 Terumo Recent Developments/Updates
6.8 Vetter
6.8.1 Vetter Company Information
6.8.2 Vetter Description and Business Overview
6.8.3 Vetter Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Vetter Prefillable COP Polymer Syringes Product Portfolio
6.8.5 Vetter Recent Developments/Updates
6.9 Catalent
6.9.1 Catalent Company Information
6.9.2 Catalent Description and Business Overview
6.9.3 Catalent Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Catalent Prefillable COP Polymer Syringes Product Portfolio
6.9.5 Catalent Recent Developments/Updates
6.10 Taisei Kako
6.10.1 Taisei Kako Company Information
6.10.2 Taisei Kako Description and Business Overview
6.10.3 Taisei Kako Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Taisei Kako Prefillable COP Polymer Syringes Product Portfolio
6.10.5 Taisei Kako Recent Developments/Updates
6.11 Roselabs Group
6.11.1 Roselabs Group Company Information
6.11.2 Roselabs Group Description and Business Overview
6.11.3 Roselabs Group Prefillable COP Polymer Syringes Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Roselabs Group Prefillable COP Polymer Syringes Product Portfolio
6.11.5 Roselabs Group Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Prefillable COP Polymer Syringes Industry Chain Analysis
7.2 Prefillable COP Polymer Syringes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Prefillable COP Polymer Syringes Production Mode & Process Analysis
7.4 Prefillable COP Polymer Syringes Sales and Âé¶¹Ô´´ing
7.4.1 Prefillable COP Polymer Syringes Sales Channels
7.4.2 Prefillable COP Polymer Syringes Distributors
7.5 Prefillable COP Polymer Syringes Customer Analysis
8 Prefillable COP Polymer Syringes Âé¶¹Ô´´ Dynamics
8.1 Prefillable COP Polymer Syringes Industry Trends
8.2 Prefillable COP Polymer Syringes Âé¶¹Ô´´ Drivers
8.3 Prefillable COP Polymer Syringes Âé¶¹Ô´´ Challenges
8.4 Prefillable COP Polymer Syringes Âé¶¹Ô´´ Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Âé¶¹Ô´´ Size Estimation
10.1.3 Âé¶¹Ô´´ Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
BD
Gerresheimer
Nipro Corporation
Schott
Baxter BioPharma Solution
Rovi CM
Terumo
Vetter
Catalent
Taisei Kako
Roselabs Group
Ìý
Ìý
*If Applicable.
